1-7 of 7
Ellappan Babu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1889: Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer

Devaraja Rajasekaran, Jiro Ogura, Mitchell Wachtel, Sabarish Ramachandran, Ellappan Babu, Sathish Sivaprakasam, Paul J. Grippo, Carolina Torres, Thangaraju Muthusamy, Jaya P. Gnana-Prakasam, Yangzom D. Bhutia
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1889.
https://doi.org/10.1158/1538-7445.AM2019-1889
Published: 01 July 2019
View articletitled, Abstract 1889: Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer
Journal Articles

Abstract 1015: Repurposing the FDA-approved drug carbidopa to treat human cancers

Vadivel Ganapathy, Ellappan Babu, Sabarish Ramachandran, Yangzom D. Bhutia
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1015.
https://doi.org/10.1158/1538-7445.AM2016-1015
Published: 15 July 2016
View articletitled, Abstract 1015: Repurposing the FDA-approved drug carbidopa to treat human cancers
Journal Articles

Abstract 1557: The iron-overload genetic disease hemochromatosis potentiates colonic inflammation and colon carcinogenesis

Vadivel Ganapathy, Ashish Gurav, Jaya P. Gnanaprakasam, Ellappan Babu, Yangzom D. Bhutia, Cynthia Reinoso Webb, Matthew B. Grisham
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1557.
https://doi.org/10.1158/1538-7445.AM2015-1557
Published: 01 August 2015
View articletitled, Abstract 1557: The iron-overload genetic disease hemochromatosis potentiates colonic inflammation and colon carcinogenesis
Journal Articles

Abstract 348: Amino acid-based prodrugs of gemcitabine - a therapeutic option to overcome chemoresistance in pancreatic cancer

Yangzom D. Bhutia, Ellappan Babu, Pankaj K. Singh, Vadivel Ganapathy
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 348.
https://doi.org/10.1158/1538-7445.AM2015-348
Published: 01 August 2015
View articletitled, Abstract 348: Amino acid-based prodrugs of gemcitabine - a therapeutic option to overcome chemoresistance in pancreatic cancer
Journal Articles

Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs

Yangzom D. Bhutia, Ellappan Babu, Sabarish Ramachandran, Vadivel Ganapathy
Journal: Cancer Research
Cancer Res (2015) 75 (9): 1782–1788.
https://doi.org/10.1158/0008-5472.CAN-14-3745
Published: 30 April 2015
View articletitled, Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs
Open the PDF for Amino Acid Transporters in Cancer and Their Relevance to “Glutamine Addiction”: Novel Targets for the Design of a New Class of Anticancer Drugs in another window
Journal Articles

Abstract 2198: Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate

Ellappan Babu, Muthusamy Thangaraju, Vadivel Ganapathy
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2198.
https://doi.org/10.1158/1538-7445.AM2011-2198
Published: 15 April 2011
View articletitled, Abstract 2198: Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
Journal Articles

Abstract 4459: a-Methyltryptophan (a-MT) inhibits estrogen receptor (ER)-positive breast cancer growth through blockade of SLC6A14

Vadivel Ganapathy, Senthil Karunakaran, Sabarish Ramachandran, Ellappan Babu, Selvakumar Elangovan, Sudharshan Periaswamy-Thandavan, Patricia V. Schoenlein, Ashish Gurav, Nagendra Singh, Puttur D. Prasad, Muthusamy Thangaraju
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4459.
https://doi.org/10.1158/1538-7445.AM2011-4459
Published: 15 April 2011
View articletitled, Abstract 4459: a-Methyltryptophan (a-MT) inhibits estrogen receptor (ER)-positive breast cancer growth through blockade of SLC6A14